Sermonix to Host KOL Fireside Chat on Advancements in the Metastatic Breast Cancer Treatment Landscape on April 22, 2024 COLUMBUS, Ohio, April 19, 2024 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat metastatic...

Sermonix to Host Virtual Clinical Update on its ELAINE Phase 2 Clinical Programs COLUMBUS, Ohio, June 09, 2022 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat ESR1-mutated...

Cancer Immunotherapy Documentary Wins Prestigious Golden Owl Award at Bergen International Film Festival Boston, MA, Oct. 08, 2019 (GLOBE NEWSWIRE) -- Uncommon Productions (“Uncommon”) is proud to announce that their latest documentary, Jim Allison: Breakthrough (“Breakthrough”) has received the 2019...

Jim Allison: Breakthrough Documentary to Open in Theaters on September 27th Boston, MA, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Uncommon Productions (“Uncommon”) will premiere their latest documentary, Jim Allison: Breakthrough (“Breakthrough”) in New York and Los Angeles on...

National Brain Tumor Society & Memorial Sloan Kettering Agreement Bolsters Research Efforts to Combat Deadliest Brain Cancer BOSTON, MA--(Marketwired - July 06, 2016) - National Brain Tumor Society (NBTS), the largest nonprofit organization in the U.S. dedicated to the brain tumor community, today announced that it has...